Cargando…
Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
Congestive cardiac failure accounts for 36% of childhood deaths in hypertrophic cardiomyopathy, and in infants with heart failure symptoms before two years of age, the mortality is extremely high unless treatment with beta-receptor antagonists is instituted. The mechanism of heart failure is not sys...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443781/ https://www.ncbi.nlm.nih.gov/pubmed/25198737 http://dx.doi.org/10.2174/1574887109666140908125158 |